| 标题 |
Dolutegravir-based and low-dose efavirenz-based regimen for the initial treatment of HIV-1 infection (NAMSAL): week 96 results from a two-group, multicentre, randomised, open label, phase 3 non-inferiority trial in Cameroon |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet HIV 作者:Alexandra Calmy; Tamara Tovar Sanchez; Charles Kouanfack; Mireille Mpoudi-Etame; Sandrine Leroy; et al 出版日期:2020-09-30 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人或该文件上传人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)